Top

Published in:

01-06-2019 | Original Article

Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence

Authors: Stefano Cianci, Carlo Ronsini, Giuseppe Vizzielli, Alessandro Tropea, Antonio Biondi, Giovanni Scambia, Anna Fagotti

Published in: Updates in Surgery | Issue 2/2019

Abstract

Secondary and tertiary cytoreductive surgery was associated with improved overall survival in platinum-sensitive recurrent ovarian cancer (ROC). Hyperthermic intraoperative intra-peritoneal chemotherapy (HIPEC) is considered an attractive method in the treatment of ROC to deliver chemotherapy with enhanced effect directly at the tumor site. However, another deserving aspect is the feasibility and the oncologic role of HIPEC repetition. Twelve patients affected by secondary ovarian cancer recurrence previously submitted to cytoreduction followed by HIPEC were enrolled for the present study to receive tertiary cytoreduction followed by HIPEC repetition. The median operative time, including time for HIPEC procedure, was 360 min (range 240–540). Average EBL was 325 ml (from 100 to 500 ml). The median hospital stay was of 5 days, from 4 to 10. Low-grade post operatory complications occurred in 2 patients (16.6%) and high-grade complication in 1 case (8.3%). Our study report encouraging data about safety of HIPEC repetition in ovarian cancer treatment.

Laganà AS, Vitale SG, Trovato MA et al (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179. https://doi.org/10.1155/2016/3617179 CrossRefPubMedPubMedCentral

Caruso S, Cianci S, Vitale SG et al (2017) Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse. Menopause 24:900–907. https://doi.org/10.1097/GME.0000000000000851 CrossRefPubMed

Caruso S, Rugolo S, Bandiera S et al (2007) Clitoral blood flow changes after surgery for stress urinary incontinence: pilot study on TVT versus TOT procedures. Urology 70:554–557. https://doi.org/10.1016/j.urology.2007.04.045 CrossRefPubMed

Lagana AS, Vitale SG, De Dominici R et al (2016) Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy a 12-years retrospective cohort study. Ann Ital Chir 87:461–465PubMed

Vitale SG, Laganà AS, Gulino FA et al (2016) Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates Surg 68:325–329. https://doi.org/10.1007/s13304-015-0343-y CrossRefPubMed

Vitale SG, Sapia F, Rapisarda AMC et al (2017) Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int 2017:6848250. https://doi.org/10.1155/2017/6848250 CrossRefPubMedPubMedCentral

Sturlese E, Triolo O, Grasso R et al (2017) Thromboembolism prophylaxis in laparoscopic surgery for gynecologic benign diseases. Results of a single center experience in 922 procedures. Ann Ital Chir 88:342–347PubMed

Di Sardo Spiezio A, Vieira MDC, Laganà AS et al (2017) Combined systemic and hysteroscopic intra-amniotic injection of methotrexate associated with hysteroscopic resection for cervical pregnancy: a cutting-edge approach for an uncommon condition. Eurasian J Med 49:66–68. https://doi.org/10.5152/eurasianjmed.2017.16215 CrossRef

Di Sardo Spiezio A, Di Guardo F, Santangelo F, Cianci S, Giampaolino P (2017) Commentary on “Assessment of risk factors of intrauterine adhesions in patients with induced abortion and the curative effect of hysteroscopic surgery”. J Investig Surg 18:1–3. https://doi.org/10.1080/08941939.2017.1400133 CrossRef

10.

Bellia A, Vitale SG, Laganà AS, Cannone F, Houvenaeghel G, Rua S, Ladaique A, Jauffret C, Ettore G, Lambaudie E (2016) Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet 294(3):615–622CrossRefPubMed

11.

Cignini P, Vitale SG, Laganà AS, Biondi A, La Rosa VL, Cutillo G (2017) Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg 69(1):75–82CrossRefPubMed

12.

Rossetti D, Vitale SG, Tropea A, Biondi A, Laganà AS (2017) New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer. Updates Surg 69(3):383–388CrossRefPubMed

13.

Tozzi R, Giannice R, Cianci S et al (2015) Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral–Peritoneal Debulking (VPD) in patients with stage IIIC–IV ovarian cancer. Gynecol Oncol 138:252–258. https://doi.org/10.1016/j.ygyno.2015.05.010 CrossRefPubMed

14.

Gueli Alletti S, Rossitto C, Cianci S, Scambia G (2016) Telelap ALF-X total hysterectomy for early stage endometrial cancer: new frontier of robotic gynecological surgery. Gynecol Oncol 140:575–576. https://doi.org/10.1016/j.ygyno.2016.01.018 CrossRefPubMed

15.

Gueli Alletti S, Rossitto C, Cianci S et al (2016) Telelap ALF-X vs standard laparoscopy for the treatment of early-stage endometrial cancer: a single-institution retrospective cohort study. J Minim Invasive Gynecol 23:378–383. https://doi.org/10.1016/j.jmig.2015.11.006 CrossRefPubMed

16.

Gueli Alletti S, Rossitto C, Perrone E et al (2017) Needleoscopic conservative staging of borderline ovarian tumor. J Minim Invasive Gynecol 24:529–530. https://doi.org/10.1016/j.jmig.2016.10.009 CrossRefPubMed

17.

Chiofalo B, Palmara V, Laganà AS et al (2017) Fertility sparing strategies in patients affected by placental site trophoblastic tumor. Curr Treat Options Oncol 18:58. https://doi.org/10.1007/s11864-017-0502-0 CrossRefPubMed

18.

Vitale SG, La Rosa VL, Rapisarda AMC, Lagana AS (2017) The importance of fertility preservation counseling in patients with gynecologic cancer. J Reprod Infertil 18:261–263PubMedPubMedCentral

19.

Vitale SG, La Rosa VL, Rapisarda AMC et al (2018) Fertility preservation in women with gynaecologic cancer: the impact on quality of life and psychological well-being. Hum Fertil (Camb) 21:35–38. https://doi.org/10.1080/14647273.2017.1339365 CrossRef

20.

Laganà AS, La Rosa VL, Rapisarda AMC et al (2017) Psychological impact of fertility preservation techniques in women with gynaecological cancer. Ecancermedicalscience 11:ed62. https://doi.org/10.3332/ecancer.2017.ed62 CrossRefPubMedPubMedCentral

21.

Gueli Alletti S, Vizzielli G, Lafuenti L, Costantini B, Fagotti A, Fedele C, Cianci S, Perrone E, Gallotta V, Rossitto C, Scambia G (2018) Single-institution propensity-matched study to evaluate the psychological effect of minimally invasive interval debulking surgery versus standard laparotomic treatment: from body to mind and back. J Minim Invasive Gynecol 25(5):816–822CrossRefPubMed

22.

Laganà AS, La Rosa VL, Rapisarda AMC et al (2017) Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health 9:323–330. https://doi.org/10.2147/IJWH.S119729 CrossRefPubMedPubMedCentral

23.

Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS (2017) Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol 38:317–319. https://doi.org/10.1080/0167482X.2016.1244185 CrossRefPubMed

24.

Rossitto C, Gueli Alletti S, Rotolo S et al (2016) Total laparoscopic hysterectomy using a percutaneous surgical system: a pilot study towards scarless surgery. Eur J Obstet Gynecol Reprod Biol 203:132–135. https://doi.org/10.1016/j.ejogrb.2016.05.007 CrossRefPubMed

25.

Gueli Alletti S, Rossitto C, Cianci S et al (2018) The Senhance^TM surgical robotic system (“Senhance”) for total hysterectomy in obese patients: a pilot study. J Robot Surg 12:229–234. https://doi.org/10.1007/s11701-017-0718-9 CrossRefPubMed

26.

Gueli Alletti S, Perrone E, Cianci S et al (2018) 3 mm Senhance robotic hysterectomy: a step towards future perspectives. J Robot Surg. https://doi.org/10.1007/s11701-018-0778-5 CrossRefPubMed

27.

Rossitto C, Cianci S, Gueli Alletti S et al (2017) Laparoscopic, minilaparoscopic, single-port and percutaneous hysterectomy: comparison of perioperative outcomes of minimally invasive approaches in gynecologic surgery. Eur J Obstet Gynecol Reprod Biol 216:125–129. https://doi.org/10.1016/j.ejogrb.2017.07.026 CrossRefPubMed

28.

Cosentino F, Vizzielli G, Turco LC et al (2018) Near-infrared imaging with indocyanine green for detection of endometriosis lesions (Gre-Endo Trial): a pilot study. J Minim Invasive Gynecol. https://doi.org/10.1016/j.jmig.2018.02.023 CrossRefPubMed

29.

Rapisarda AMC, Cianci A, Caruso S et al (2018) Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management. Arch Gynecol Obstet 297:1353–1375. https://doi.org/10.1007/s00404-018-4728-2 CrossRefPubMed

30.

Gallotta V, Conte C, Giudice MT et al (2017) Secondary laparoscopic cytoreduction in recurrent ovarian cancer: a large, single-institution experience. J Minim Invasive Gynecol 25:644–650. https://doi.org/10.1016/j.jmig.2017.10.024 CrossRefPubMed

31.

Fagotti A, Costantini B, Gallotta V et al (2015) Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes. J Minim Invasive Gynecol 22:428–432. https://doi.org/10.1016/j.jmig.2014.11.008 CrossRefPubMed

32.

Fanfani F, Fagotti A, Ercoli A et al (2015) Is there a role for tertiary (TCR) and quaternary (QCR) cytoreduction in recurrent ovarian cancer? Anticancer Res 35:6951–6955PubMed

33.

Bristow RE, Puri I, Chi DS (2009) Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol 112:265–274. https://doi.org/10.1016/j.ygyno.2008.08.033 CrossRefPubMed

34.

Petrillo M, De Iaco P, Cianci S et al (2016) Long-term survival for platinum-sensitive recurrent ovarian cancer patients treated with secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol 23:1660–1665. https://doi.org/10.1245/s10434-015-5050-x CrossRefPubMed

35.

Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41. https://doi.org/10.1159/000180580 CrossRefPubMed

36.

Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132CrossRefPubMedPubMedCentral

37.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral

38.

Issels RD (2008) Hyperthermia adds to chemotherapy. Eur J Cancer 44:2546–2554. https://doi.org/10.1016/j.ejca.2008.07.038 CrossRefPubMed

39.

Fagotti A, Costantini B, Vizzielli G et al (2011) HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome. Gynecol Oncol 122:221–225. https://doi.org/10.1016/j.ygyno.2011.04.008 CrossRefPubMed

40.

Cianci S, Vizzielli G, Fagotti A et al (2018) A novel HIPEC technique using hybrid CO₂ recirculation system: intra-abdominal diffusion test in a porcine model. Updates Surg. https://doi.org/10.1007/s13304-018-0557-x CrossRefPubMed

41.

Cianci S, Abatini C, Fagotti A et al (2018) Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid CO₂ system: preliminary experience in referral center. Updates Surg. https://doi.org/10.1007/s13304-018-0578-5 CrossRefPubMed

42.

Paris I, Cianci S, Vizzielli G et al (2018) Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer. Int J Hyperth. https://doi.org/10.1080/02656736.2018.1503346 CrossRef

43.

Falcone F, Scambia G, Benedetti Panici P et al (2017) Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: a multicentre MITO retrospective study. Gynecol Oncol 147:66–72. https://doi.org/10.1016/j.ygyno.2017.07.008 CrossRefPubMed

44.

Vitale SG, Caruso S, Rapisarda AMC et al (2018) Isoflavones, calcium, vitamin D and inulin improve quality of life, sexual function, body composition and metabolic parameters in menopausal women: result from a prospective, randomized, placebo-controlled, parallel-group study. Prz Menopauzalny 17:32–38. https://doi.org/10.5114/pm.2018.73791 CrossRefPubMedPubMedCentral

45.

Caruso S, Cianci S, Fava V et al (2018) Vaginal health of postmenopausal women on nutraceutical containing equol. Menopause 25:430–435. https://doi.org/10.1097/GME.0000000000001061 CrossRefPubMed

46.

Caruso S, Cianci S, Cariola M et al (2017) Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17β-Estradiol. J Womens Health (Larchmt) 26:728–734. https://doi.org/10.1089/jwh.2016.5801 CrossRef

47.

Caruso S, Cianci S, Cariola M et al (2017) Effects of nutraceuticals on quality of life and sexual function of perimenopausal women. J Endocrinol Investig 40:27–32. https://doi.org/10.1007/s40618-016-0500-2 CrossRef

48.

Caruso S, Rapisarda AM, Cianci S (2016) Sexuality in menopausal women. Curr Opin Psychiatry 29:323–330. https://doi.org/10.1097/YCO.0000000000000280 CrossRefPubMed

49.

Caruso S, Cianci S, Amore FF et al (2016) Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Menopause 23:47–54. https://doi.org/10.1097/GME.0000000000000485 CrossRefPubMed

50.

Caruso S, Agnello C, Malandrino C et al (2014) Do hormones influence women’s sex? Sexual activity over the menstrual cycle. J Sex Med 11:211–221. https://doi.org/10.1111/jsm.12348 CrossRefPubMed

Title: Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence
Authors: Stefano Cianci
Carlo Ronsini
Giuseppe Vizzielli
Alessandro Tropea
Antonio Biondi
Giovanni Scambia
Anna Fagotti
Publication date: 01-06-2019
Publisher: Springer International Publishing
Published in: Updates in Surgery / Issue 2/2019
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-018-0600-y

At a glance: The STEP trials

Springer Medicine

Cytoreductive surgery followed by HIPEC repetition for secondary ovarian cancer recurrence

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2019

The impact of experience on short- and long-term outcomes on gastric ESD: a western series

Laparoscopic resection of splenic flexure colon cancers: a retrospective multi-center study with 117 cases

A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures

The obesity paradox in beyond total mesorectal excision surgery for locally advanced and recurrent rectal cancer

“Complex abdominal wall” management: evidence-based guidelines of the Italian Consensus Conference

Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery